Cargando…
U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study
In October 2014, the Drug Enforcement Administration in the U.S. reclassified hydrocodone combination products (HCPs) from Schedule III to Schedule II, initiating one of the most significant and controversial regulatory changes for opioids in recent national history. The aim of the present study was...
Autores principales: | Covvey, Jordan R., Pfalzgraf, Andrea R., Cohron, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597174/ https://www.ncbi.nlm.nih.gov/pubmed/28975908 http://dx.doi.org/10.3390/pharmacy3030129 |
Ejemplares similares
-
Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic
por: Ngo, John, et al.
Publicado: (2020) -
A survey of the views and capabilities of community pharmacists in Western Australia regarding the rescheduling of selected oral antibiotics in a framework of pharmacist prescribing
por: Sinkala, Fatima, et al.
Publicado: (2018) -
Patterns of abuse and routes of administration for immediate‐release hydrocodone combination products
por: Cassidy, Theresa A., et al.
Publicado: (2017) -
LHC launch rescheduled
Publicado: (2008) -
Pharmacist and Student Knowledge and Perceptions of Herbal Supplements and Natural Products
por: Stayduhar, Jacey M., et al.
Publicado: (2023)